---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-027943"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2024-08-28T23:59:59+00:00"
generated_at: "2026-05-31T07:08:55.833123+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vistagen stockholders elect all seven director nominees, approve say-on-pay, ratify auditors at 2024 annual meeting

## Summary
- All seven director nominees elected, including CEO Shawn K. Singh with 14,540,841 votes for and 154,427 withheld.
- Non-binding advisory vote on executive compensation approved: 13,758,902 for, 842,393 against, 93,973 abstain.
- Ratification of KPMG LLP as independent auditor for FY2025 overwhelmingly approved: 21,277,275 for, 49,205 against.
- Meeting held August 26, 2024; results reported in 8-K filed August 28, 2024.

## SEC filing metadata
- accession: 0001437749-24-027943
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2024-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000143774924027943/0001437749-24-027943-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000143774924027943/vtgn20240827_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-027943
- JSON: https://secwatch.observer/filing/0001437749-24-027943.json
- Plain text: https://secwatch.observer/filing/0001437749-24-027943.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.